| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF COMMUNICATION |
Departments of Obstetrics & Gynecology and Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas 66160
Address all correspondence and requests for reprints to: Warren B. Nothnick, Ph.D., Department of Obstetrics and Gynecology, University of Kansas School of Medicine, 3901 Rainbow Blvd., Kansas City, Kansas 66160. E-mail: wnothnic{at}kumc.edu
Abstract
TIMP-1 is a multifunctional protein that is abundantly expressed within the ovary during the period of early corpus luteum formation. TIMP-1 has been suggested to play a role in progesterone production, but reports are conflicting. To more thoroughly examine the role of TIMP-1 in steroidogenesis during early luteal development in vivo, immature wild-type and TIMP-1 null female mice were primed with gonadotropins. Mice were sacrificed at 0, 24, and 48 h post hCG administration and serum was collected for determination of estradiol (E2) or progesterone (P4) concentrations. In the 24 h hCG groups, ovulation was assessed by counting the number of shed ova. Serum P4 concentrations were significantly lower in the TIMP-1 null mice, both at 24 and 48-h post hCG compared to wild-type counterparts. No differences were detected in the number of ovulations between genotypes at the 24 h time point. In both the 24 and 48 h post-hCG groups, null mice had significantly higher ovarian wet weights. Interestingly, ovarian MMP activity was greater in the null mice at 24 h post hCG but higher in the wild-type at 48 h post hCG administration. These observations suggests that expression of TIMP-1 during early luteal development may participate in regulation of progesterone production via its ability to regulate ovarian MMP activity.
This article has been cited by other articles:
![]() |
E. Bruegmann, R. Gruemmer, J. Neulen, and K. Motejlek Regulation of soluble vascular endothelial growth factor receptor 1 secretion from human endothelial cells by tissue inhibitor of metalloproteinase 1 Mol. Hum. Reprod., November 1, 2009; 15(11): 749 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gerin, G. W. Louis, X. Zhang, T. C. Prestwich, T. R. Kumar, M. G. Myers Jr., O. A. MacDougald, and W. B. Nothnick Hyperphagia and Obesity in Female Mice Lacking Tissue Inhibitor of Metalloproteinase-1 Endocrinology, April 1, 2009; 150(4): 1697 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wahlberg, I. Boden, J. Paulsson, L. R. Lund, K. Liu, and T. Ny Functional Corpora Lutea Are Formed in Matrix Metalloproteinase Inhibitor-Treated Plasminogen-Deficient Mice Endocrinology, March 1, 2007; 148(3): 1226 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Nothnick, X. Zhang, and H.-E Zhou Steroidal Regulation of Uterine Edema and Tissue Inhibitors of Metalloproteinase (TIMP)-3 Messenger RNA Expression Is Altered in TIMP-1-Deficient Mice Biol Reprod, February 1, 2004; 70(2): 500 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |